Literature DB >> 11794475

Clinical and MRI assessment of brain damage in MS.

G Comi1, M Rovaris, L Leocani, V Martinelli, M Filippi.   

Abstract

Cognitive impairment in multiple sclerosis (MS), generally in the form of the so-called subcortical dementia, results predominantly by the disruption of communication among cortical and subcortical areas, consequent to white matter damage. Studies with conventional magnetic resonance imaging (MRI) demonstrated that cognitive impairment in MS patients is related to lesion burden, although the strength of this correlation is weak. This can be partially explained by the poor pathological specificity of conventional MRI techniques and by damage in the normal-appearing white matter (NAWM). This interpretation is supported by studies using non-conventional MRI techniques, more specific to the heterogeneous substrates of MS pathology, such as the assessment of hypointense lesion load on T1-weighted scans and the measurement of the magnetization transfer ratio (MTR) of whole brain, MS lesions and NAWM. Other factors, such as the site of MS lesions and the presence of active inflammation, also seem to play an important role.

Entities:  

Mesh:

Year:  2001        PMID: 11794475     DOI: 10.1007/s100720100049

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  2 in total

1.  Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.

Authors:  Rosario Megna; Bruno Alfano; Roberta Lanzillo; Teresa Costabile; Marco Comerci; Giovanni Vacca; Antonio Carotenuto; Marcello Moccia; Giuseppe Servillo; Anna Prinster; Vincenzo Brescia Morra; Mario Quarantelli
Journal:  J Neurol       Date:  2018-11-29       Impact factor: 4.849

2.  Effects of Venous Angioplasty on Cerebral Lesions in Multiple Sclerosis: Expanded Analysis of the Brave Dreams Double-Blind, Sham-Controlled Randomized Trial.

Authors:  Paolo Zamboni; Roberto Galeotti; Fabrizio Salvi; Alessia Giaquinta; Carlo Setacci; Salvatore Alborino; Giuseppe Guzzardi; Salvatore J Sclafani; Elisa Maietti; Pierfrancesco Veroux
Journal:  J Endovasc Ther       Date:  2019-11-17       Impact factor: 3.487

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.